173 related articles for article (PubMed ID: 22985631)
21. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
22. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
24. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
[TBL] [Abstract][Full Text] [Related]
25. Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV.
Stevenson NJ; Murphy AG; Bourke NM; Keogh CA; Hegarty JE; O'Farrelly C
PLoS One; 2011; 6(11):e27866. PubMed ID: 22114715
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
King RW; Zecher M; Jefferies MW
Antivir Chem Chemother; 2002 Nov; 13(6):363-70. PubMed ID: 12718408
[TBL] [Abstract][Full Text] [Related]
28. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.
Zhang L; Jilg N; Shao RX; Lin W; Fusco DN; Zhao H; Goto K; Peng LF; Chen WC; Chung RT
J Hepatol; 2011 Aug; 55(2):289-98. PubMed ID: 21147189
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication.
Chou WW; Huang CF; Yeh ML; Tsai YS; Hsieh MY; Huang CI; Huang JF; Tsai PC; Hsi E; Juo SH; Tsai WL; Chuang WL; Yu ML; Dai CY
J Mol Med (Berl); 2016 Mar; 94(3):311-20. PubMed ID: 26489607
[TBL] [Abstract][Full Text] [Related]
30. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
Zhu H; Butera M; Nelson DR; Liu C
Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
32. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
[TBL] [Abstract][Full Text] [Related]
34. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
35. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.
Lin K; Kwong AD; Lin C
Antimicrob Agents Chemother; 2004 Dec; 48(12):4784-92. PubMed ID: 15561857
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hepatitis C virus replication by antimonial compounds.
Hwang DR; Lin RK; Leu GZ; Lin TY; Lien TW; Yu MC; Yeh CT; Hsu JT
Antimicrob Agents Chemother; 2005 Oct; 49(10):4197-202. PubMed ID: 16189098
[TBL] [Abstract][Full Text] [Related]
38. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
39. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway.
Heim MH; Moradpour D; Blum HE
J Virol; 1999 Oct; 73(10):8469-75. PubMed ID: 10482599
[TBL] [Abstract][Full Text] [Related]
40. HCV infection selectively impairs type I but not type III IFN signaling.
Chandra PK; Bao L; Song K; Aboulnasr FM; Baker DP; Shores N; Wimley WC; Liu S; Hagedorn CH; Fuchs SY; Wu T; Balart LA; Dash S
Am J Pathol; 2014 Jan; 184(1):214-29. PubMed ID: 24215913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
